The application of normal, SV40 T-antigen-immortalised and tumour-derived oral keratinocytes, under serum-free conditions, to the study of the probability of cancer progression as a result of environmental exposure to chemicals

Alternatives to Laboratory Animals : ATLA
Rebecca CederR C Grafström

Abstract

In vitro models are currently not considered to be suitable replacements for animals in experiments to assess the multiple factors that underlie the development of cancer as a result of environmental exposure to chemicals. An evaluation was conducted on the potential use of normal keratinocytes, the SV40 T-antigen-immortalised keratinocyte cell line, SVpgC2a, and the carcinoma cell line, SqCC/Y1, alone and in combination, and under standardised serum-free culture conditions, to study oral cancer progression. In addition, features considered to be central to cancer development as a result of environmental exposure to chemicals, were analysed. Genomic expression, and enzymatic and functional data from the cell lines reflected many aspects of the transition of normal tissue epithelium, via dysplasia, to full malignancy. The composite cell line model develops aberrances in proliferation, terminal differentiation and apoptosis, in a similar manner to oral cancer progression in vivo. Transcript and protein profiling links aberrations in multiple gene ontologies, molecular networks and tumour biomarker genes (some proposed previously, and some new) in oral carcinoma development. Typical specific changes include the loss of tumour-supp...Continue Reading

References

May 15, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·D M ThomsonA E Clague
Sep 9, 1992·International Journal of Cancer. Journal International Du Cancer·K Sundqvist, R C Grafström
Jul 1, 1991·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·K SundqvistR C Grafström
Apr 1, 1991·Clinical Oral Implants Research·K ArvidsonI Ericsson
May 1, 1996·European Journal of Cancer. Part B, Oral Oncology·H Raybaud-DiogèneR A Monteil
Jan 1, 1997·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·R C GrafströmK Sundqvist
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Nov 14, 2000·The American Journal of Pathology·J J HedbergR C Grafström
Mar 10, 2001·Carcinogenesis·M VondracekR C Grafström
Jul 13, 2001·Current Opinion in Genetics & Development·F M Watt
Feb 14, 2002·Critical Reviews in Oncology/hematology·Shi-Yong Sun, Reuben Lotan
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Martin VondracekRoland C Grafström
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Karin AnnertzJohan Wennerberg
Feb 1, 2003·European Journal of Oral Sciences·Annette HanssonRoland C Grafström
May 24, 2003·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·Jesper Reibel
Feb 28, 2004·The Journal of Nutrition·Guoyao WuNancy D Turner
Mar 9, 2004·Cellular and Molecular Life Sciences : CMLS·J A NilssonR C Grafström
Oct 19, 2004·Seminars in Cancer Biology·Gerald N WoganLawrence A Loeb
Feb 3, 2005·Nature Reviews. Cancer·Keith D HunterPaul R Harrison
Oct 6, 2005·Cancer Research·Matthew LockeIan C Mackenzie
Nov 30, 2005·Journal of Internal Medicine·B Fadeel, S Orrenius
May 16, 2006·Chemical Research in Toxicology·Daniel C Liebler
Aug 4, 2006·Cancer Research·Keith D HunterPaul R Harrison
Sep 5, 2006·Cancer Research·Jason J Christiansen, Ayyappan K Rajasekaran

❮ Previous
Next ❯

Citations

Jun 21, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Ravi P SubramaniamPaul White
May 2, 2014·Basic & Clinical Pharmacology & Toxicology·Pekka KohonenRoland Grafström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis